Regulation of Endothelial Cell Specialization
Karen K. Hirschi, Ph.D.
Director, Developmental Genomics Center
Professor, Department of Cell Biology
University of Virginia
In Person Pioneers in Biomedical Research Seminar: Regulation of Endothelial Cell Specialization
Date: Sept. 16, 2022
Time: 11 a.m. - 12 p.m.
Archived video
About this Seminar
During the process of blood vessel development, primordial endothelial cells are formed and become specified toward arterial or venous fates to generate a circulatory network that provides nutrients and oxygen to, and removes metabolic waste from, all tissues. Specification of arterial and venous endothelial cells occurs in conjunction with suppression of endothelial cell cycle progression, and endothelial cell hyperproliferation is associated with potentially lethal arterial-venous malformations. However, the mechanistic role that cell cycle state plays in arterial-venous specification has been unknown. Dr. Hirschi’s studies demonstrate that endothelial cell cycle control plays a key role in arterial-venous network formation, and distinct cell cycle states provide distinct windows of opportunity for the molecular induction of arterial vs. venous specification. This work has broad implications for vascular tissue engineering and regenerative medicine, as well as the treatment of vascular disorders.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Vascular and Heart Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
Why Measure? , homeSept. 17, 2026, 5:30 p.m. (Reception at 5 p.m.) | Christopher S. Hourigan, DM, DPhil, FRCP, Professor and Director, Cancer Research Center — D.C., Fralin Biomedical Research Institute | Maury Strauss Distinguished Public Lecture
-
Home Item
Brown Adipose Tissue as a Mediator of Cardiovascular Health , homeSept. 18, 2026, 11:00 a.m. | Kristin Stanford, Ph.D., FAHA, Professor, Department of Surgery; William D. and Jacquelyn L. Wells Chair, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Exercise Medicine Research
-
Home Item
mTor Signaling in Pulmonary Vascular Disease: Bench to Bedside and Back , homeSept. 25, 2026, 11:00 a.m. | Elena Goncharova, Ph.D., ATSF, FAHA, Professor, Department of Internal Medicine; Director, Pulmonary Vascular Disease Program, UC Davis School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Vascular and Heart Research
-
Home Item
How Can Research Inform Better Public Policy Towards Addiction? , homeOct. 2, 2026, 11:00 a.m. | Keith Humphreys, OBE, Ph.D., Esther Ting Memorial Professor, Department of Psychiatry, Stanford University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research
-
Home Item
Exercise, the Fountain of Youth? , homeOct. 15, 2026, 5:30 p.m. (Reception at 5 p.m.) | Zhen Yan, Ph.D., Professor and Director, Center for Exercise Medicine Research, Fralin Biomedical Research Institute at VTC | Maury Strauss Distinguished Public Lecture
-
Home Item
Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies , homeOct. 16, 2026, 11:00 a.m. | Peng Jiang, Ph.D., Senior Investigator, National Cancer Institute, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute and the Cancer Research Center — D.C.